Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism BTK C481S inhibitors(Bruton Tyrosine Kinase C481S inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H27ClN4O3 |
InChIKeyPNEJGHMXVOJHCG-KDURUIRLSA-N |
CAS Registry2639293-95-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Leukemia | Preclinical | China | 09 May 2025 | |
| Lymphoma | Preclinical | China | 09 May 2025 |





